The performance of companies tied to iconic drugs like Viagra presents a challenging investment landscape . While the initial rise of copyright, fueled by Viagra's remarkable popularity, generated substantial wealth , the patent expiration in key regions has introduced significant uncertainty . Investors are now grappling with the impact of lower-c